Skip to main content
Kao-Ping Chua, MD, Pediatrics, Ann Arbor, MI

Kao-Ping Chua MD PhD

Pediatrics•Ann Arbor, MI

Associate Professor of Pediatrics, University of Michigan Medical School

Join to View Full Profile

  • 2800 Plymouth RoadNCRC Building 16, SPC 2800, Room G026WAnn Arbor, MI 48109

  • Phone+1 734-615-8169

Dr. Chua is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Chua's Full ProfileAlready have an account?

Education & Training

  • Harvard University
    Harvard UniversityPh.D., Health Policy, 2011
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2007 - 2010
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2007

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2017 - 2027
  • IL State Medical License
    IL State Medical License 2015 - 2020
  • MA State Medical License
    MA State Medical License 2010 - 2017
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Academic Pediatric Association Young Investigator Award, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Estimates from Heterogeneous Studies of Opioid-Related Morbidity  
    Kao-Ping Chua, MD, JAMA Pediatrics
  • Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients with Type 1 Diabetes  
    Kao-Ping Chua, MD, JAMA Pediatrics
  • Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients with Type 1 Diabetes  
    Kao-Ping Chua, MD, JAMA Internal Medicine
  • Join now to see all

Authored Content

  • Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19August 2020
  • Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19August 2020
  • Out-of-Pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014October 2018
  • Effect of FDA Investigation on Opioid Prescribing to Children After Tonsillectomy/AdenoidectomyDecember 2017
  • Effect of FDA Investigation on Opioid Prescribing to Children After Tonsillectomy/AdenoidectomyNovember 2017
  • Join now to see all

Press Mentions

  • Obtaining ADHD Drugs via Telehealth Could Increase Addiction Risk
    Obtaining ADHD Drugs via Telehealth Could Increase Addiction RiskMarch 5th, 2025
  • Kennedy Thrusts Antidepressants into the Spotlight as Doctors and Advocates Defend Them
    Kennedy Thrusts Antidepressants into the Spotlight as Doctors and Advocates Defend ThemFebruary 21st, 2025
  • Stimulant Prescriptions Rebound to Pre-Pandemic Levels for Girls, Not Boys
    Stimulant Prescriptions Rebound to Pre-Pandemic Levels for Girls, Not BoysFebruary 4th, 2025
  • Join now to see all

Grant Support

  • Insurance-related barriers to medications for opioid use disorder in private and Medicaid plansUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
  • Evaluating Policy Interventions to Decrease Excessive and Risky Perioperative Opioid PrescribingUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
  • Using Default Opioid Prescription Settings to Limit Excessive Opioid Prescribing to Adolescents and Young AdultsNational Institute on Drug Abuse2019–2024

Professional Memberships

External Links

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Kao-Ping Chua, Dr. Kao-Ping Chua, MD, Dr. K Chua